Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease-Reference-Cited by-同舟云学术

Omalizumab reduces cysteinyl leukotriene and 9α,11β-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease

Published:2016-05 Issue:5 Volume:137 Page:1585-1587.e4
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Hayashi Hiroaki,Mitsui Chihiro,Nakatani Eiji,Fukutomi Yuma,Kajiwara Keiichi,Watai Kentaro,Sekiya Kiyoshi,Tsuburai Takahiro,Akiyama Kazuo,Hasegawa Yoshinori,Taniguchi Masami

Funder

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference15 articles.

1. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma;Fischer;J Allergy Clin Immunol,1994

2. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects;Christie;Am Rev Respir Dis,1991

3. Clinical and pathologic perspectives on aspirin sensitivity and asthma;Stevenson;J Allergy Clin Immunol,2006

4. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature;Rajan;J Allergy Clin Immunol,2015

5. New strategies with anti-IgE in allergic diseases;Holgate;World Allergy Organ J,2014

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review of NSAID Hypersensitivity Reactions Based on Clinical Phenotyping;Journal of Clinical Rheumatology and Immunology;2024-06-22

2. Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update;Brazilian Journal of Otorhinolaryngology;2024-05

3. Biologic Therapies across Nasal Polyp Subtypes;Journal of Personalized Medicine;2024-04-19

4. Quality of Life in NSAIDs-Exacerbated Respiratory Disease on or off Intranasal Lysine Aspirin Therapy;Applied Sciences;2024-01-30

5. Hypersensitivity to intravenous succinate corticosteroids in patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease;Frontiers in Allergy;2023-11-10